Code of Ethics
1. General framework and guiding principles
Medicina y Seguridad del Trabajo (hereinafter MST; standardised abbreviated title Med Segur Trab) is a quarterly scientific journal published by the National School of Occupational Medicine of the Carlos III Health Institute. Its purpose is to disseminate, with scientific rigour and a public-service vocation, research and knowledge on occupational medicine, occupational health, occupational risk prevention, occupational diseases and other aspects relevant to protecting the health of workers. This Code of Ethics is the master document that governs the journal’s editorial conduct and structures its other policies.
MST expressly adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors (ICMJE), the Code of Conduct and Best Practice Guidelines for Journal Editors of the Committee on Publication Ethics (COPE), the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME and OASPA), the Declaration of Helsinki of the World Medical Association in its current revision, and the recommendations of the EQUATOR Network for research reporting.
1.1. Guiding principles
Editorial activity is governed by six non-negotiable principles: scientific integrity, editorial independence, transparency, fairness and impartiality, confidentiality and public service. These principles take precedence over any commercial, political or personal consideration in editorial decision-making.
- Scientific integrity: published content must be truthful, original, reproducible and based on rigorous methods.
- Editorial independence: publication decisions rest exclusively with the editorial team, free from external influence.
- Transparency: policies, procedures, funding sources and conflicts of interest are public and verifiable.
- Fairness and impartiality: manuscripts are assessed on their scientific quality, regardless of the sex, gender, identity, sexual orientation, age, origin, nationality, beliefs or affiliation of the authors.
- Confidentiality: information on manuscripts under review is treated as confidential by everyone involved in the process.
- Public service: as the publication of a public research body, MST contributes to knowledge on occupational health and to the improvement of working conditions.
1.2. Relationship with other journal policies
This Code of Ethics provides the common framework and is developed through specific policies that remain separate documents for reasons of visibility and indexing. These companion policies are accessible from the “Editorial Policy” section of the website:
- Peer review policy and guide for reviewers.
- Author contributions policy.
- Plagiarism detection policy.
- Open access policy and privacy policy.
- Gender equality policy.
- Informed consent for publication policy.
- Advertising policy.
- Data sharing policy.
2. Duties of the editorial team
The editorial team comprises the Director, the Associate Editors and the Editorial Board. Their responsibilities, derived from the COPE Code of Conduct and the ICMJE recommendations, are as follows.
2.1. Publication decisions
The editorial team is responsible for the final decision on the publication of submitted manuscripts. The decision is based on scientific quality, originality, clarity of presentation, methodological soundness and relevance to the journal’s scope. Assessments based on the sex, gender, identity, sexual orientation, age, origin, nationality, beliefs, institutional affiliation, ideology or any other personal circumstance of the authors are not permitted. The journal ensures compliance with current legislation on copyright, data protection and respect for the good name of individuals and institutions.
2.2. Editorial independence
The editorial line, thematic planning, selection of manuscripts and peer review criteria are the exclusive responsibility of the editorial team. No advertiser, sponsor, funder or interested party may influence editorial decisions. Where a manuscript is authored by members of the editorial team or editorial office, its evaluation will be handled by a member of the team who is unconnected with the manuscript, thus ensuring impartiality.
2.3. Confidentiality and custody of manuscripts
Neither the members of the editorial team nor any other person associated with the journal will disclose information about submitted manuscripts to anyone other than the authors, the reviewers and, where appropriate, the oversight and supervisory bodies, and only to the extent strictly necessary. Unpublished material may not be used, cited or reproduced without the written permission of the authors.
2.4. Conflicts of interest of the editorial team
Members of the editorial team will declare in writing any financial, professional, personal or institutional relationships that a reasonable reader might consider relevant, using the ICMJE Disclosure of Interestform. Where there is a conflict of interest regarding a particular manuscript, the person concerned will refrain from taking part in its evaluation and decision.
2.5. Ethical oversight of published content
The editorial team actively monitors published content. It investigates allegations of misconduct, keeps the relevant documentation and applies the procedures described in section 9 of this Code where appropriate. It cooperates with the authors’ institutions, funders and the competent bodies in any investigations that may be required.
3. Duties of reviewers
Peer review is the journal’s core quality-control mechanism. Reviewers provide an essential service to the scientific community and to the journal itself, and their work is governed by the following duties.
3.1. Cooperation with the editorial team
The purpose of peer review is to assist the editorial team in making publication decisions and to help improve the quality of manuscripts. Reviews are carried out constructively, with clear and verifiable arguments, and within the agreed deadlines.
3.2. Diligence and competence
Any reviewer who considers that they lack the expertise needed to assess a manuscript, or who is unable to carry out the review with the required diligence, will inform the editorial team and decline the review.
3.3. Confidentiality
Manuscripts under review are considered confidential documents. They may not be shown, discussed or disseminated without the express authorisation of the editorial team. Information obtained during the review may not be used for personal advantage or for the benefit of third parties.
3.4. Objectivity
Reviews are conducted objectively, without personal criticism and with scientifically grounded arguments. The manuscript is assessed on its content, regardless of any consideration relating to the authors.
3.5. Identification of sources and detection of overlap
Reviewers will inform the editorial team of any published work related to the manuscript that has not been cited, and will report any substantial similarity or overlap between the manuscript and other publications of which they are aware.
3.6. Conflicts of interest
Reviewers will refrain from reviewing manuscripts with which they have conflicts of interest arising from competitive, collaborative, personal, financial or institutional relationships. They will inform the editorial team of any circumstance that might compromise their impartiality.
3.7. Use of artificial intelligence in peer review
In accordance with the ICMJE recommendations on the use of AI by reviewers, manuscripts under review may not be uploaded, in whole or in part, to generative artificial intelligence tools whose terms of use allow the content to be incorporated into their training models. Any use of AI during the review must be declared to the editorial team. Ultimate responsibility for the review always lies with the reviewer.
4. Duties of authors
4.1. Quality and reproducibility
Authors submit original research, clearly presented, with verifiable data and methods described in sufficient detail to allow the study to be reproduced by others. Where a reporting guideline applies to the type of study (CONSORT, STROBE, PRISMA, CARE, ARRIVE, etc.), the manuscript will follow it. Any false, intentionally inaccurate or unfounded statement is considered an ethical breach and grounds for rejection.
4.2. Originality, plagiarism and proper citation
Manuscripts must be original and must not have been previously published in any medium, except in the cases accepted by editorial practice (duly declared preprints, conference communications in abstract form, authorised translations). Authors will properly cite the sources underpinning their work, including previous work that was decisive in conceiving the study. MST applies automated similarity and plagiarism checks.
4.3. Authorship and contribution
Authorship is reserved for those who have made substantial contributions in accordance with the four ICMJE criteria: substantial contribution to the conception or design of the work, or to the acquisition, analysis or interpretation of data; drafting or critically revising the manuscript; approval of the final version; and agreement to be accountable for all aspects of the work. The corresponding author undertakes to obtain the express approval of the final version from all co-authors and to ensure that the author list meets these criteria. Contributions that do not meet the threshold for authorship are acknowledged in the acknowledgements section.
4.4. Multiple, redundant or duplicate publication
Work already published elsewhere, or manuscripts simultaneously under review by another journal, must not be submitted to the journal. Secondary publication is acceptable only in the cases provided for by the ICMJE (for example, translations of interest to different audiences), with the explicit consent of the rights holders and a visible reference to the original place of publication.
4.5. Declaration of funding and conflicts of interest
Authors will declare all sources of funding for the study, without exception, in the corresponding section of the manuscript. They will also declare any financial, professional or personal conflict of interest using the ICMJE form. The declaration is published together with the article.
4.6. Data and code sharing
Authors will make the primary data and materials associated with the manuscript available under the terms set out in the journal’s data sharing policy, respecting the applicable legal and ethical limits. Where the analysis depends on source code, its deposit in a public repository with a persistent identifier is encouraged.
4.7. Errors in published work
If, after publication, authors detect significant errors or inaccuracies in their work, they must notify the editorial team without delay and cooperate in the correction, rectification or, where appropriate, retraction of the article, in accordance with section 9 of this Code.
5. Research ethics
All research published in MST must have been planned, conducted and reported in accordance with internationally accepted ethical principles for research involving human beings, personal data and, where applicable, laboratory animals. This section sets out these principles in detail and forms an integral part of the journal’s editorial policy. It is supplemented by the journal’s informed consent policy.
5.1. Approval by a research ethics committee
All research involving human beings, their biological samples or their personal data must have received a favourable opinion from an independent, accredited research ethics committee, under the terms of Law 14/2007 of 3 July on Biomedical Research; Royal Decree 1090/2015 of 4 December on clinical trials with medicinal products; Regulation (EU) 2016/679 (GDPR); and Organic Law 3/2018 of 5 December on the Protection of Personal Data and Guarantee of Digital Rights. The methods section of the manuscript will identify the committee that issued the opinion, its location and, where applicable, the reference number and date of approval. MST may request a copy of the opinion at any stage of the editorial process.
In occupational medicine and occupational health research based on data previously collected through health surveillance, health examinations, risk assessments or information systems on occupational accidents and diseases — particularly relevant to MST given the nature of its content — the manuscript will describe precisely the legal basis for processing the data and, where applicable, the justified exemption from ethics committee review. The journal reserves the right to request further clarification if the justification is considered insufficient.
5.2. Declaration of Helsinki and CIOMS
Research involving human beings must respect the ethical principles of the Declaration of Helsinki of the World Medical Association in its current revision, as well as the International Ethical Guidelines for Health-related Research Involving Humans of the Council for International Organizations of Medical Sciences (CIOMS), where applicable.
5.3. Research with laboratory animals
Manuscripts describing procedures on laboratory animals will state compliance with Royal Decree 53/2013 of 1 February and Directive 2010/63/EU, and will report results in accordance with the ARRIVE 2.0guidelines. The authorised body that approved the procedures and the authorised facility where they were carried out must be identified.
5.4. Clinical trial registration
Clinical trials must have been prospectively registered, before enrolment of the first participant, in a public registry recognised by the WHO or in ClinicalTrials.gov. The registration number will appear in the abstract and in the methods section, in accordance with section L of the ICMJE recommendations.
5.5. Data sharing
In line with the FAIR principles and the open science model of the Carlos III Health Institute, the journal promotes the responsible sharing of the data underlying published results. Manuscripts will include a data sharing statement specifying which data are shared, where, when and under what access conditions. Where data cannot be shared for legitimate reasons, the statement will set out the reasons and, where possible, offer alternatives (aggregated or synthetic data, code, statistical plan). The specific conditions are set out in the journal’s data sharing policy.
5.6. Sex and gender perspective in research
In keeping with the institutional policy of the ISCIII, the journal recommends integrating the sex and gender perspective into the design, analysis and reporting of results, and reporting disaggregated data where relevant to the interpretation of occupational risks and the effects of work on health.
6. Confidentiality, data protection and informed consent
MST guarantees, in all its articles, respect for the right to privacy and to the protection of the personal data of patients, workers taking part in research and third parties mentioned in manuscripts, in accordance with section II.E of the ICMJE Recommendations, Regulation (EU) 2016/679 (GDPR), Organic Law 3/2018 and Law 41/2002 of 14 November on patient autonomy.
6.1. Confidentiality in the editorial process
The journal treats all submitted manuscripts and associated information as confidential. Access to manuscripts under review is restricted to the editorial team, the designated reviewers and, where strictly necessary, technical support staff. Personal information about authors and reviewers is processed in accordance with the journal’s privacy policy.
6.2. Informed consent for publication
Authors must obtain written informed consent, specific to publication, whenever a manuscript contains information that could directly or indirectly allow a person to be identified — including clinical photographs, detailed case descriptions, videos, ultrasound images with metadata, genomic sequences or sufficiently specific combinations of sociodemographic and occupational data. Simple partial masking of images is not considered sufficient anonymisation. The signed copy of the consent remains with the authors and the responsible institution; the journal may request an anonymised copy at any time.
The precise conditions, the cases in which consent is not required, the rules applicable to minors and persons with modified legal capacity, and the suggested templates are set out in the MST Informed Consent Policy, which forms an integral part of this Code of Ethics.
6.3. Protection of personal data
Any processing of personal data associated with publications complies with the GDPR and the LOPDGDD (Spanish Data Protection Act). Research using data previously collected in workplace health surveillance systems, registries of occupational accidents and diseases, occupational health records or other health or administrative records must describe the legal basis and the safeguards adopted. Pseudonymisation is not equivalent to anonymisation; therefore, the dissemination of identifiable or re-identifiable data requires a specific legal basis.
7. Conflicts of interest and transparency
Transparency about the financial, professional and personal relationships surrounding a scientific publication is a condition of its credibility. MST applies a unified conflict of interest disclosure policy that applies equally to authors, reviewers and members of the editorial team.
7.1. Definition and scope
A conflict of interest is any financial, professional, personal or institutional circumstance that could reasonably influence, or appear to influence, a person’s judgement regarding a manuscript. It includes, but is not limited to, employment, consultancies, fees, intellectual property, shares or options, grants, scholarships, paid travel, gifts, public statements, family ties and institutional commitments.
7.2. Mandatory disclosure
Authors declare conflicts of interest over the previous thirty-six months using the ICMJE Disclosure of Interestform. The declaration is published with the article. The deliberate omission of a relevant conflict is considered scientific misconduct and is handled in accordance with section 8 of this Code.
7.3. Funding
The study’s sources of funding are declared explicitly and in full in the manuscript. In studies funded by industry, mutual insurance companies collaborating with the Social Security system, occupational risk prevention services or other entities with interests in occupational health, the manuscript will state whether, and to what extent, the funder was involved in the design, conduct, analysis, writing or decision to publish.
7.4. Sponsorships and partnerships
Sponsorship or institutional partnership agreements will respect the journal’s editorial independence and comply with the advertising policy and the ICMJE recommendations on sponsorships and partnerships.
8. Scientific integrity and prevention of misconduct
The journal is committed to the integrity of the research it publishes and actively promotes the prevention and detection of scientific misconduct.
8.1. Unacceptable conduct
The following, among others, are considered scientific misconduct:
- Fabrication or falsification of data.
- Improper manipulation of images, figures or statistical results.
- Plagiarism, self-plagiarism and improper text recycling.
- Inappropriate authorship (gift, ghost or commissioned authorship).
- Undeclared duplicate or redundant publication, or salami slicing.
- Deliberate omission of relevant conflicts of interest.
- Manipulation of the peer review process.
- Research involving human beings or animals without the required ethical approvals.
8.2. Prevention
MST applies preventive checks to all manuscripts: verification of authorship, automated similarity and plagiarism checks, technical review of images and data consistency, and verification of statements on funding, conflicts of interest, ethical approvals and clinical trial registration. The journal trains its editorial team in the COPE guidelines and consults its flowcharts in doubtful cases.
8.3. Investigation of suspected misconduct
Any well-founded suspicion of misconduct, whether raised by the editorial team, reviewers, readers, authors or third parties, is investigated with discretion and proportionality, giving the persons involved the opportunity to be heard. Where appropriate, the journal will contact the authors’ institution of affiliation and, where applicable, the funding body, requesting that the corresponding institutional procedure be opened.
8.4. Outcomes
If misconduct is confirmed, the measures set out in section 9 will be applied: correction, editorial expression of concern or retraction, depending on the seriousness and verifiability of the problem. Where the conduct is of disciplinary or criminal relevance, the competent bodies will be notified. The journal may bar further submissions from the persons involved for a reasonable period, with written reasons.
9. Procedure for corrections, retractions and editorial expressions of concern
MST maintains a clear, reproducible and public procedure for handling errors and suspected misconduct in published articles, consistent with sections III.A and III.B of the ICMJE Recommendations and with the COPE Retraction Guidelines (2025).
9.1. Types of post-publication action
9.1.1. Correction (corrigendum / erratum)
A correction is appropriate when an error is identified that affects part of the article’s content but does not compromise its main conclusions or the overall reliability of the results. This includes errors in figures, names, affiliations, figure legends, inadvertently omitted funding sources, or passages in the results section which, once corrected, do not change the conclusions. The correction notice is published with a visible title, a full citation of the original article and a two-way link. The original article is updated with a notice indicating that a correction exists and linking to it.
9.1.2. Editorial expression of concern
An expression of concern is appropriate when there is verifiable evidence that justifies alerting readers to the reliability of an article, but there are not yet sufficient grounds for a retraction. It is the appropriate instrument, for example, while an institutional investigation is under way, when a party involved does not respond, or when the available information is contradictory. The expression of concern is published as a separate notice, not merely as a letter to the editor, on a numbered page listed in the table of contents, with a title that reproduces that of the affected article and a two-way link to the original.
9.1.3. Retraction
A retraction is appropriate when it is established that the article’s conclusions are unreliable owing to error, fabrication or falsification of data, improper image manipulation, substantial plagiarism, false authorship, serious omission of relevant conflicts or undeclared duplication. The retraction notice is published as separate, clearly labelled editorial content, with a full citation of the original article and an explanation of the reason. The retracted article remains accessible in the public domain but is unambiguously marked as retracted — in the HTML version, the PDF and the abstract. Metadata sent to the secondary databases in which the journal is indexed are updated accordingly.
9.2. Initiation of the procedure
Anyone may report a possible error or a well-founded suspicion of misconduct to the editorial team by writing to the editorial contact address and identifying the article, the problem and, where possible, the available evidence. MST guarantees the confidentiality of the person reporting, unless otherwise required by law, and rules out any retaliation arising from a report made in good faith.
9.3. Preliminary assessment and investigation
The Director, assisted by the Editorial Board, assesses the plausibility and seriousness of the problem, consulting the applicable COPE flowchart where appropriate. If the problem is minor and verifiable, the correction procedure is initiated. If there are reasonable doubts about the integrity of the work, the authors are asked to provide a reasoned explanation within a reasonable period, which may be extended where justified. Where the matter requires an institutional investigation, the journal will contact the institution of affiliation and, where applicable, the funding body; in the meantime, the article may be flagged with a provisional editorial expression of concern.
9.4. Decision and reasons
The final decision rests with the Director, after consulting the Editorial Board, and is reasoned in writing. The journal informs the authors and, where appropriate, the institutions involved of the decision taken and the grounds on which it is based.
9.5. Format and visibility of notices
Correction notices, expressions of concern and retraction notices are primary editorial content: they appear in the table of contents with their own page number, are indexable and are deposited in institutional repositories with the corresponding metadata. The title of the notice includes that of the affected article. In the electronic edition, the affected article carries a permanent notice visible from both the abstract and the full text.
9.6. Communication to secondary databases
Correction notices, editorial expressions of concern and retraction notices are transmitted to the secondary databases in which the journal is indexed (SciELO, DOAJ, IBECS, Virtual Health Library, Latindex, ÍnDICEs CSIC, MIAR, CAB Abstracts, CUIDEN, Dialnet, REPIDISCA and others), following the technical procedures established by each of them, so that each notice links correctly to the article on the corresponding platform.
9.7. Appeals
Authors may appeal an editorial decision by sending a reasoned letter to the Director within thirty days of notification. The appeal is examined by a person or committee other than the one that took the initial decision and is resolved in writing with reasons. This decision exhausts the editorial process.
10. Use of artificial intelligence
In accordance with section V of the ICMJE Recommendations on the use of AI, generative artificial intelligence tools cannot be listed as authors or assume authorial responsibilities. Their use — including writing assistants, image generation or editing, data analysis or literature review — must be specifically declared in the methods section or the acknowledgements, indicating the tool, its version and the purpose for which it was used. Ultimate responsibility for the content always lies with the authors.
Reviewers may not upload manuscripts under review, not even fragments, to AI tools whose terms of use allow the content to be incorporated into their training models. Any use of AI in the review will be declared to the editorial team. The editorial team, for its part, may use AI tools for ancillary tasks (similarity checks, formal checks) under conditions of confidentiality and human supervision.
11. Equality, diversity and inclusion
The journal is committed to real equality between women and men, to inclusive language and to integrating the sex and gender perspective into scientific output. It applies active measures to ensure a balanced composition of the editorial team and the panel of reviewers, in accordance with the journal’s own gender equality policy.
The journal also promotes geographical, institutional and disciplinary diversity among authors and reviewers, and seeks to facilitate the participation of those working in lower-resource settings.
12. Complaints, grievances and appeals
Authors, reviewers, readers and, in general, any interested party may send complaints, grievances or suggestions to the editorial team regarding the functioning of the journal, its editorial decisions or published content. Communications should be sent to the editorial contact address and will be dealt with within a reasonable period.
Appeals against editorial decisions are examined by a person or committee other than the one that took the initial decision, in accordance with the COPE Complaints and Appealsflowchart. The outcome is notified in writing with reasons and exhausts the editorial process.





